IL-1 plays an important role in mediating tumor-stromal IL-6/STAT3 crosstalk in the #TumorMicroenvironment which provides a preclinical rationale for targeting IL-1 signaling as a therapeutic strategy in #PDAC. https://t.co/4jFRQdIGqi https://t.co/pY61yedx
RT @FrillePelle: ”These data highlight the importance of IL1 in mediating tumor–stromal IL6/STAT3 cross-talk in the TME and provide a precl…
IL-1 plays an important role in mediating tumor-stromal IL-6/STAT3 crosstalk in the #TumorMicroenvironment which provides a preclinical rationale for targeting IL-1 signaling as a therapeutic strategy in #PDAC. https://t.co/BnNcjUjjjf https://t.co/OwhRvFIw
RT @FrillePelle: ”These data highlight the importance of IL1 in mediating tumor–stromal IL6/STAT3 cross-talk in the TME and provide a precl…
RT @FrillePelle: ”These data highlight the importance of IL1 in mediating tumor–stromal IL6/STAT3 cross-talk in the TME and provide a precl…
RT @FrillePelle: ”These data highlight the importance of IL1 in mediating tumor–stromal IL6/STAT3 cross-talk in the TME and provide a precl…
”These data highlight the importance of IL1 in mediating tumor–stromal IL6/STAT3 cross-talk in the TME and provide a preclinical rationale for targeting IL1 signaling as a therapeutic strategy in PDAC.” Spännande att se Cantargia’s PFS & OS i PDAC i Q
IL-1 plays an important role in mediating tumor-stromal IL-6/STAT3 crosstalk in the #TumorMicroenvironment, which provides a preclinical rationale for targeting IL-1 signaling as a therapeutic strategy in #PDAC. https://t.co/8drXdj7z5o https://t.co/ZcdPqsv
RT @DrJashDatta: Excellent paper on targeting IL6/STAT3 via IL1 receptor inhibition in #PancreaticCancer by @theNCI #T32 research fellow Au…
RT @DrJashDatta: Excellent paper on targeting IL6/STAT3 via IL1 receptor inhibition in #PancreaticCancer by @theNCI #T32 research fellow Au…
RT @FrillePelle: "the combination of anakinra with cytotoxic chemotherapy significantly extends overall survival compared with vehicle trea…
RT @DrJashDatta: Excellent paper on targeting IL6/STAT3 via IL1 receptor inhibition in #PancreaticCancer by @theNCI #T32 research fellow Au…
RT @FrillePelle: "the combination of anakinra with cytotoxic chemotherapy significantly extends overall survival compared with vehicle trea…
RT @DrJashDatta: Excellent paper on targeting IL6/STAT3 via IL1 receptor inhibition in #PancreaticCancer by @theNCI #T32 research fellow Au…
RT @DrJashDatta: Excellent paper on targeting IL6/STAT3 via IL1 receptor inhibition in #PancreaticCancer by @theNCI #T32 research fellow Au…
RT @DrJashDatta: Excellent paper on targeting IL6/STAT3 via IL1 receptor inhibition in #PancreaticCancer by @theNCI #T32 research fellow Au…
RT @DrJashDatta: Excellent paper on targeting IL6/STAT3 via IL1 receptor inhibition in #PancreaticCancer by @theNCI #T32 research fellow Au…
#canfour $canta
RT @FrillePelle: "the combination of anakinra with cytotoxic chemotherapy significantly extends overall survival compared with vehicle trea…
"the combination of anakinra with cytotoxic chemotherapy significantly extends overall survival compared with vehicle treatment or anakinra monotherapy" As did Cantargia's antibody CAN04 significantly extend PDAC patients OS in the CANFOUR trial with 50%
RT @DrJashDatta: Excellent paper on targeting IL6/STAT3 via IL1 receptor inhibition in #PancreaticCancer by @theNCI #T32 research fellow Au…
RT @DrJashDatta: Excellent paper on targeting IL6/STAT3 via IL1 receptor inhibition in #PancreaticCancer by @theNCI #T32 research fellow Au…
RT @DrJashDatta: Excellent paper on targeting IL6/STAT3 via IL1 receptor inhibition in #PancreaticCancer by @theNCI #T32 research fellow Au…
Excellent paper on targeting IL6/STAT3 via IL1 receptor inhibition in #PancreaticCancer by @theNCI #T32 research fellow Austin Dosch, who did PhD under @NbmerchantMD tutelage in lab yrs, published in @MCT_AACR. Lots more from our lab on IL1 signaling soon!
Researchers highlight the importance of IL-1 in mediating tumor-stromal IL-6/STAT3 crosstalk in the TME and provide preclinical rationale for targeting IL-1 signaling as a therapeutic strategy in #pancreatic ductal adenocarcinoma. 🙌 https://t.co/EObnSBQT
New article: Targeting tumor-stromal IL-6/STAT3 signaling through IL-1 receptor inhibition in pancreatic cancer https://t.co/6waz1fYd2R #pancreaticcancer #oncology https://t.co/OLbr2nWsTL